Artificial enzymes programmed to destroy SARS-CoV-2

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus.

Genes identified to potentially diagnose Lyme disease

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease.

How stealthy HIV evades drugs and immunity

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, researchers at Duke Health in the US report.

Tech news: December 2022

Maine Standards

Documentation Platforms

Bone marrow organoids

This technology will allow for the screening of multiple anti-cancer drugs at the same time, as well as testing personalised treatments for individual cancer patients.

Novel device to measure nerve activity

The device, described in an article in Scientific Reports, has potential applications for supporting more personalised treatments for sepsis and mental health conditions, such as

Haematuria and chronic kidney disease

They also found that the association was significantly stronger in men, in comparison to women.

Personalised breast cancer screening

The research, presented in November at the 13th European Breast Cancer Conference, could make breast screening programmes more effective and improve survival rates.

Detecting of SARS CoV-2 in wastewater

During the pandemic, Japan has had a low number of cases per capita.

Biopsy, diagnostics and tumour removal

Normally, with a surgical biopsy for a glioma, the surgeon collects a tissue sample, the lab then runs tests to diagnose and, depending on the treatment plan, a second surgical operation